Accelerating medical tech to advance public health

An ever-expanding landscape of new medical products and therapies demands an equally fast-moving evolution of regulatory actions and policy. From brand new drugs to insulin delivery devices and cancer screening equipment, agencies including the Food & Drug Administration and the Center for Drug Evaluation & Research face the challenges of rapidly evolving science and technology. (more…)